Viatris Inc. (VTRS)
Nasdaq · Common stock · Pharmaceutical Preparations
As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow VTRS in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on VTRS and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
VTRS at a glance
Key statistics
$21.42B
Market capitalization
- Previous close
- $18.65
- Open
- $18.60
- Day range
- $18.44 – $18.70
- Volume
- 2.34M
- Average volume (30 sessions)
- 9.38M
- Shares outstanding
- 1.15B
- Earnings per share
- $(0.36)
- Price / book
- 1.5
- Price / sales
- 1.4
- Beta (1 year, vs SPY)
- 0.67
Where the price sits in its year
52-week range
98% of the range
- Below the 52-week high
- -0.9%
- Above the 52-week low
- +87.2%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $17.76+5.0%
- 50-day average
- $17.06+9.3%
- 200-day average
- $15.66+19.1%
Between the conventional 30 and 70 bands.
+8.1%
1 week
+9.1%
1 month
+9.6%
3 months
+49.8%
Year to date
+83.4%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with VTRS
VTRS on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on VTRS.
See the plans →
Every planScreen names like VTRS
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on VTRS
Put VTRS on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on VTRS
See whether there is an open premium alert on VTRS, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
VTRS headlines
- Viatris at $14: A Double-Digit FCF Yield Hiding in Plain Sight
Investing.com · Apr 2, 2026
- Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend
Benzinga · Feb 26, 2026
- Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs
Benzinga · Oct 9, 2025
- VTRS CLASS NOTICE: Viatris Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS)
GlobeNewswire Inc. · May 31, 2025
- VTRS FRAUD: Suffer Losses on Viatris Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law (NASDAQ:VTRS)
GlobeNewswire Inc. · May 25, 2025
SEC Form 4, most recent first
Insider filings
Groothuis Leo Frans
+2.5K
Director · Grant or award
$43.75K · Sep 30, 2026
SIMMONS DAVID S
+2.1K
Director · Grant or award
$37.51K · Sep 30, 2026
Enrietti Andrew
−998.364
See Remarks · Option exercise
· Aug 15, 2026
Enrietti Andrew
+999
See Remarks · Option exercise
· Aug 15, 2026
Enrietti Andrew
−10.9K
See Remarks · Shares withheld for tax
$177.41K · Aug 15, 2026
Enrietti Andrew
−435
See Remarks · Shares withheld for tax
$7.06K · Aug 15, 2026
Enrietti Andrew
+25.1K
See Remarks · Option exercise
· Aug 15, 2026
Enrietti Andrew
−25.1K
See Remarks · Option exercise
· Aug 15, 2026
About Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Pharmaceutical Preparations
- Headquarters
- Canonsburg, PA
- Employees
- 30,000
- Listed since
- Feb 23, 1973
- Website
- viatris.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.